Cabaletta Bio (CABA) Stock Highlights

4.91 | +1.24%

2024-10-21 04:26:39

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAAR, T cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CAAR T cell product candidate was designed based on the clinically validated and commercially approved Chimeric Antigen Receptor, or CAR, T cell technology that is marketed for the treatment of B cell cancers.

Statistics

Range Today

4.68 4.95

Volume Today 539.3K

Range 1 Year

3.47 26.35

Volume 1 Year 285.84M

Range 3 Year

0.59 26.35

Volume 3 Year 627.25M

Range 10 Year

0.59 26.35

Volume 10 Year 685.64M

Highlights

Market Capitalization 239.6M (small)

Floating Shares 41.31M

Current Price 4.91

Price To Earnings -2.55

Price To Book 1.19

Earnings Per Share -1.91

Payout Ratio 0%

Performance

Latest +1.24%

1 Month +17.46%

3 Months -35.31%

6 Months -67.27%

1 Year -65.74%

3 Years -59.49%

5 Years -45.44%

10 Years -45.44%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.